Bicycle Therapeutics plc (BCYC)

NASDAQ: BCYC · Real-Time Price · USD

5.33

+0.19 (3.70%)

At close: Apr 17, 2026, 4:00 PM EDT

5.34

+0.01 (0.27%)

After-hours: Apr 17, 2026, 4:36 PM EDT

Bicycle Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	372	491	967	767	879	1,790
Market Cap Growth	-33.31%	-49.19%	26.03%	-12.72%	-50.89%	367.95%
Enterprise Value	-240	-151	87	241	561	1,563
Last Close Price	5.33	7.08	14.00	18.08	29.60	60.87
PS Ratio	5.12	6.77	27.40	28.43	60.76	152.99
PB Ratio	0.61	0.81	1.22	2.07	3.25	5.17
P/TBV Ratio	0.61	0.81	1.22	2.07	3.25	5.17
EV/Sales Ratio	-	-	2.46	8.92	38.82	133.63
Debt / Equity Ratio	0.03	0.03	0.01	0.12	0.16	0.13
Net Debt / Equity Ratio	-1.00	-1.00	-1.10	-1.30	-1.09	-1.14
Net Debt / EBITDA Ratio	2.59	2.59	4.32	2.63	2.61	6.14
Net Debt / FCF Ratio	2.42	2.42	5.24	7.58	2.81	23.44
Asset Turnover	0.09	0.09	0.05	0.05	0.03	0.04
Quick Ratio	11.65	11.65	13.61	7.92	6.76	12.43
Current Ratio	11.98	11.98	13.81	8.08	6.93	12.65
Return on Equity (ROE)	-31.21%	-31.21%	-29.04%	-56.31%	-36.54%	-30.25%
Return on Assets (ROA)	-18.13%	-18.13%	-16.81%	-23.60%	-16.38%	-12.80%
Return on Capital Employed (ROCE)	-36.80%	-36.80%	-23.50%	-36.10%	-32.70%	-14.80%
Earnings Yield	-58.93%	-44.58%	-17.49%	-23.55%	-12.83%	-3.73%
FCF Yield	-67.83%	-51.32%	-17.17%	-8.29%	-11.96%	-0.94%
Buyback Yield / Dilution	-19.02%	-19.02%	-63.54%	-20.00%	-18.35%	-30.90%

Updated Mar 17, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q